Cordlife proposes to merge with NY-listed life sciences enterprise

Singapore

CORDLIFE Group on Tuesday said that it has made an indicative, non-binding and conditional proposal to merge with New York-listed Global Cord Blood Corporation.

Global Cord Blood Corporation provides cord blood collection, laboratory testing, haematopoietic stem cell processing and stem cell storage services in China. It is incorporated in the Cayman Islands and listed on the New York Stock Exchange (NYSE).